Maternal Pertussis Wholecell Responses

PHASE2CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Pertussis
Interventions
BIOLOGICAL

Standard of care vaccines

Visit 1: Check tetanus immunisation status. Vaccination up to 25+ 6 weeks of pregnancy with Td; Visit 2: vaccination at least 4 weeks after visit 2 with either Tdap or Td (per randomisation and according to WHO guidance)

BIOLOGICAL

Boostagen, (BioNet-Asia)

Visit 1: Check tetanus immunisation status. Vaccination up to 25+ 6 weeks of pregnancy with Td; Visit 2: vaccination at least 4 weeks after visit 2 with either Tdap or Td (per randomisation and according to WHO guidance);

Trial Locations (1)

Unknown

MUJHU Care Ltd, Kampala

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

University of British Columbia

OTHER

collaborator

Public Health England

OTHER_GOV

collaborator

MU-JHU CARE

OTHER

collaborator

BioNet-Asia

UNKNOWN

lead

St George's, University of London

OTHER